52 Week Range
As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay
Haba Laboratories Inc <4925.T>: Says it names Noriko Koyanagi as president .Says effective April 1.
Haba Laboratories Inc <4925.T>: Says the co plans to merge its wholly owned unit, a Tokyo-based cosmetics firm .Says effective on March 30.
HABA LABORATORIES INC:To issue a year-end dividend of 20 yen per share to all the shareholders of record as of March 31, for FY ended March 2015.Payment date June 8.Says latest dividend forecast was 20 yen per share.
HABA LABORATORIES INC:Says Masatomo Tanaka to resign from position of president.Appoints Eiji Suehiro as president.Effective June 21.
HABA LABORATORIES INC:Top shareholder, chairman decreased stake in the company to 0 pct from 33.9 pct (1,334,000 shares) on March 6.Tokyo-based charitable organization increased stake in the company to 33.9 pct (1,334,000 shares) from 0 pct on March 6.
HABA LABORATORIES INC:Says wholly owned Hokkaido-based subsidiary that has been engaged in manufacture and sale of cosmetics, to merge its wholly owned Hokkaido-based subsidiary that has been engaged in manufacture and sale of dietary supplement and other foods.Says sub-subsidiary to be dissolved after transaction.Planned effective March 31.
HABA LABORATORIES INC:Says the company lowered the consolidated full-year outlook for the FY ending March 2015.Revenue forecast decreased to 13,160 million yen from 14,100 million yen.Operating profit forecast decreased to 340 million yen from 1,280 million yen.Ordinary profit forecast decreased to 290 million yen from 1,210 million yen.Net profit forecast decreased to 130 million yen from 730 million yen.Earnings per share decreased to 33.05 yen from 185.57 yen.Comments that increased consumption tax rate and increased advertising and sale expense are the main reasons for the forecast.
HABA LABORATORIES INC:Appoints Masatomo Tanaka as president to replace Toshinori Sugawara.Effective June 22.
HABA LABORATORIES INC:To pay year-end dividend of 20 yen per share, in line with latest dividend forecast, for fiscal year 2014.Record date March 31 and effective date June 9.
HABA LABORATORIES INC:Says it expects an extraordinary profit of 473 million yen for FY ended March 2014 and recorded as gain on land expropriation subsidy.Says the company amended the consolidated full-year outlook for the FY ended March 2014.Revenue forecast decreased to 13,786 million yen from 14,000 million yen.Operating profit forecast increased to 1,254 million yen from 1,050 million yen.Ordinary profit forecast increased to 1,207 million yen from 1,000 million yen.Net profit forecast increased to 916 million yen from 600 million yen.Earnings per share increased to 232.95 yen from 152.53 yen.Comments that effective cost control is the main reason for the forecast.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.